Document Detail

Pregnancy and commonly used drugs in hematology practice.
MedLine Citation:
PMID:  21239787     Owner:  NLM     Status:  In-Data-Review    
When a woman suffering from a hematological condition is contemplating pregnancy, she may need to continue the use of medications that do not have sufficient evidence of fetal safety. We discuss the evidence existing for some therapies of major hematological conditions in the context of major principles in clinical teratology. It is critical to always balance the potential fetal risks of the drug in question against the maternal and fetal risks of the untreated hematological condition.
Gideon Koren; Michael Lishner
Related Documents :
21278977 - Screening and management of diethylstilbestrol exposed offspring.
21395907 - Decreased fetal movement prompts investigation of prenatal/neonatal nemaline myopathy: ...
21463427 - Retrospective evaluation of perinatal outcome in women with mild gestational hyperglyce...
9449217 - 5-alpha-dihydroprogesterone formation in human placenta from 5alpha-pregnan-3beta/alpha...
24165327 - Dna methylation as a biomarker for preeclampsia.
17642997 - Anaerobes in bacterial vaginosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program     Volume:  2010     ISSN:  1520-4383     ISO Abbreviation:  Hematology Am Soc Hematol Educ Program     Publication Date:  2010  
Date Detail:
Created Date:  2011-01-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100890099     Medline TA:  Hematology Am Soc Hematol Educ Program     Country:  United States    
Other Details:
Languages:  eng     Pagination:  160-5     Citation Subset:  IM    
1Motherisk Program, University of Toronto, Toronto, Ontario, Canada and.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recombinant Factor VIIa: An Assessment of Evidence Regarding Its Efficacy and Safety in the Off-Labe...
Next Document:  Consultative hematology: the pregnant patient pregnancy loss.